ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,895Medicare Part D Prescriptions Filled, Including Refills

Rank: 306 out of 2170

$425K Total Retail Price of All Prescriptions

Rank: 609 out of 2170

561 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 561 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

4% of this provider’s 8,936 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
AMLODIPINE BESYLATE 470 395 1 4
HYDROCHLOROTHIAZIDE 425 341 2 9
OMEPRAZOLE 386 285 3 2
LOVASTATIN 310 252 4 34
FUROSEMIDE 302 237 5 6
LEVOTHYROXINE SODIUM 299 278 6 5
HYDROCODONE-ACETAMINOPHEN 286 181 S3 7 7
LISINOPRIL 283 240 8 3
GLYBURIDE MICRONIZED 257 196 R 9 236
SIMVASTATIN 249 232 10 1
ATENOLOL 241 210 11 23
METFORMIN HCL 237 176 12 8
TRAMADOL HCL 226 191 13 18
METOPROLOL TARTRATE 200 175 14 10
POTASSIUM CHLORIDE 165 144 15 16
SERTRALINE HCL 163 126 16 25
ZOLPIDEM TARTRATE 154 129 17 17
GABAPENTIN 150 124 18 14
RANITIDINE HCL 142 122 19 40
CITALOPRAM HBR 141 137 20 19
WARFARIN SODIUM 139 110 21 15
METOPROLOL SUCCINATE 138 106 22 13
LOSARTAN POTASSIUM 131 117 23 21
ALENDRONATE SODIUM 118 118 24 36
PAROXETINE HCL 117 99 25 65
ISOSORBIDE MONONITRATE ER 110 95 26 50
TRIAMTERENE-HCTZ 109 107 27 66
QUINAPRIL HCL 100 66 28 117
SYNTHROID 100 100 28 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 99 78 30 20
KLOR-CON M20 89 76 31 68
ALLOPURINOL 82 61 32 29
CLOPIDOGREL 81 69 33 37
BENAZEPRIL HCL 80 69 34 55
AZITHROMYCIN 79 64 35 47
TRAZODONE HCL 72 54 36 38
CARVEDILOL 70 61 37 26
CALCITONIN-SALMON 67 56 38 266
ATORVASTATIN CALCIUM 65 61 39 12
PLAVIX 64 59 40 58
CRESTOR 63 45 41 24
TAMSULOSIN HCL 61 46 42 33
ETODOLAC 60 46 43 218
OXYBUTYNIN CHLORIDE ER 59 58 44 148
ENALAPRIL MALEATE 55 36 45 64
PRAVASTATIN SODIUM 55 52 45 11
KLOR-CON M10 55 43 45 132
FLUTICASONE PROPIONATE 53 22 48 30
PREDNISONE 52 45 49 41
CLONIDINE HCL 51 45 50 54
FLUOXETINE HCL 50 31 51 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 14, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.